“HBcrAg Levels May Predict HBV Rebound and HBsAg Seroconversion after Nucleoside Analogue Cessation in Resolved HBV Infection: A Case Report”

https://pubmed.ncbi.nlm.nih.gov/38115129

This case report suggests that hepatitis B core-related antigen (HBcrAg) levels may predict hepatitis B virus (HBV) rebound and subsequent HBsAg seroconversion after nucleoside analogue cessation in patients with resolved HBV infection.